Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

PURPOSE: Preclinical models suggest that the use of anti–vascular endothelial growth factor (anti-VEGF) therapy with antiestrogens may prevent or delay the development of endocrine therapy resistance. We therefore performed a feasibility study to evaluate the safety of letrozole plus bevacizumab in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Traina, Tiffany A., Rugo, Hope S., Caravelli, James F., Patil, Sujata, Yeh, Benjamin, Melisko, Michele E., Park, John W., Geneus, Stephanie, Paulson, Matthew, Grothusen, Jill, Seidman, Andrew D., Fornier, Monica, Lake, Diana, Dang, Chau, Robson, Mark, Theodoulou, Maria, Flombaum, Carlos D., Norton, Larry, Hudis, Clifford A., Dickler, Maura N.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3940895/
https://ncbi.nlm.nih.gov/pubmed/19841327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.8784
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados